Seize new opportunities for the development of metropolitan areas to make established enterprises glow with new vitality
Release time:
2020-08-14
Seizes New Opportunities for Metropolitan Area Development Brings New Vitality to Old Enterprises
Zhejiang News Client Reporter Qian Key
Zhejiang Jianfeng Group Co., Ltd. is an old enterprise in Jinhua. It has a history of 59 years since the first generation of peak people founded Jinhua Cement Factory in 1958 . From the initial small cement plant to the current cement, medicine, health products, warehousing and logistics as a supplement, cross-industry, cross-regional comprehensive enterprise group, the peak has embarked on its own development path.
In the past two years, affected by the downward pressure of the economy, some companies have been in trouble, but the spikes have bucked the trend, and good news has spread frequently. In the past five years, the average annual profit of the peak has exceeded 2.5 .8 billion yuan, and the total profit and tax paid has been 8.27 billion yuan. In the past 2016 , operating income 23.79 .4 billion and net profit 2.85 .6 billion, creating the best results in peak history. In the first quarter report of 2017 , net profit 1.12 billion yuan, once again setting a new quarterly performance record.
Under the background of "walking in the forefront and jointly building Jinhua", this year, the Jinhua Municipal Party Committee and the Municipal Government have proposed to vigorously promote the comprehensive transportation corridor, Jinyi Kechuang Corridor, and Zhejiang Central Ecological Corridor. The "Three Corridor Construction" strategic deployment has drawn a new blueprint for Jinhua's future economic and social development. In the face of new opportunities, Jiang Xiaomeng, chairman of Jianfeng Group, said that as the fourth largest metropolitan area in the province, the construction of Jinhua's "three corridors" will certainly have a positive and far-reaching impact on the trend of related industries and the positioning of enterprises in central Zhejiang. The majority of business operators and businessmen should actively participate in the new wave of reform and development, and seriously think about how to combine the construction needs of the "three corridors", give play to play to the enterprise itself, so as to catch the "big car" of Jinhua's economic development, while promoting local economic development, enable enterprises to grow better and faster.
Stick to Industry Unshakable, Five Aspects "Stick to" Re-innovate Performance
Over the years, Jianfeng Group has been sticking to Industry. This has also become an iron law for the development of the peak industry. 1993 7 March 28 , Jianfeng Group's shares were successfully listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry. After years of exploration and integration of 20 , the peak finally formed a business pattern with cement and medicine as the main industry and health products, international trade and warehousing and logistics as the supplement.
Today's peak, from cement, medicine to warehousing, logistics, the system is more perfect. In the face of the achievements made in the past few years, Jiang Xiaomeng, chairman of Jianfeng Group, said that it was the land of Jinhua that nurtured the growth of Jianfeng, and striving to do a good job in the enterprise is the best return to Jinhua. He said, "Spike has been doing industry for more than 50 years and will not leave industry in the future".
Cement and medicine are all fully competitive industries. Why can an old company achieve such good new results? Jiang Xiaomeng believes that in addition to continuously strengthening the adjustment of its own industrial structure in accordance with the changes in the economic environment, the sound development of the peak in recent years has benefited from the persistence of five aspects: adhere to the development strategy of "cooperative innovation to strengthen the main business, standardize science and seek development"; adhere to accurate market positioning according to its own reality, that is, leading the cost of cement and being a niche in the regional market, leading pharmaceutical technology, leading enterprise in product market segmentation, natural raw materials in health product industry and leader in health product innovation; A control system of "strict budget effective authorization" has been established and implemented persistently. It has a management team that is united and pragmatic, pioneering and innovative, with reasonable age composition and solid and comprehensive knowledge structure. After several generations of peak people continuously refined and enriched, A corporate culture that meets the needs of peak reality and development has been formed.
Enterprise development of the effectiveness of the heavy, energy conservation and environmental protection at all costs to invest
as a leading enterprise at the level of Jinhua City, the sharp peak group will be for the "three corridors" construction of what "action"? Faced with this problem, Jiang Xiaomeng said, the peak in recent years has been doing industrial restructuring, in fact, and Jinhua "three corridors" overall construction framework fit.
In terms of ecological development, as early as ten years ago, Jianfeng had consciously transferred the high-pollution and high-emission cement industry to other places, using local resource advantages and market advantages to vigorously promote environmental protection and energy-saving transformation such as waste heat power generation, desulfurization, and denitration while making profits, and successfully realized the upgrading of traditional industries; based on Jinhua's Jianfeng pharmaceutical industry, the Jinxi production base with an investment of 5.8 .6 billion yuan has been fully put into operation in 2015 . From the beginning of the design, it has set high standards for energy conservation, emission reduction and comprehensive utilization of resources. Peak Health, a new enterprise, uses natural plants as raw materials to produce and sell healthy products. It has already made a lot of investment in the construction of ecological raw material bases, emission reduction and environmental protection.
Among them, in terms of environmental protection construction, Peak will continue to invest 3 million yuan in the next three years to carry out emission rectification.
In terms of transportation and logistics, the board of directors of Jianfeng Group held recently passed a resolution to invest 7 million yuan in jindong district to build a modern e-commerce park, which is beneficial and complementary to Jianfeng's original bonded storage, logistics, futures delivery and other businesses. In addition, the construction of traffic corridors is bound to have a large number of engineering construction, which will also bring new development opportunities to the cement building materials industry. The new strategy of
focuses on the future. Scientific and technological innovation promotes the transformation and upgrading of enterprises
. In terms of scientific and technological innovation, Jianfeng Pharmaceutical has established the research and development idea of "2 " with anti-infective drugs, cardiovascular and cerebrovascular drugs, drugs for elderly children and anti-tumor drugs as the main line, antidepressant drugs and eye drops as supplements, and timely entering the field of biological agents, extensive and in-depth cooperation with relevant universities and research institutes.
If Professor Wang Guangji, an academician of the Chinese Academy of Engineering, is hired as the chief scientist, the national first-class anti-tumor new drug being developed by his scientific research team has been included in the national major innovation plan this year; Sichuan Antibiotic Research Institute, which has been cooperating with Jianfeng for many years, is currently planning to establish a branch in Jinhua, further cooperation with Spike Pharmaceuticals in product, business and technical exchanges... These will lay a good foundation for Spike Pharmaceuticals to upgrade its products and expand its industry.
In addition to the above aspects, Jianfeng will invest more than 3 million yuan in the near future to upgrade the original drug production line to the US and EU standard GMP to create basic conditions for preparation products to go abroad. Guangxi Huibaoyuan Pharmaceutical Technology Company, which has recently participated in the reorganization, has introduced experts and technologies from Yale University in the United States to conduct innovative research and development and production; in Jinhua's pharmaceutical enterprises, only the planned investment in product research and development has reached 1.5 .8 billion yuan. Jiang Xiaomeng said that the provincial government and the municipal government recently issued support policies to reduce corporate taxes, which provided new assistance for enterprises to participate in the construction of the "three corridors. Jinhua's enterprises and entrepreneurs should seize this favorable opportunity to participate in the construction of the "three corridors" and contribute to Jinhua's economic and social development.
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31